Clover Health Investments (CLOV) to Release Earnings on Tuesday

Clover Health Investments (NASDAQ:CLOV - Get Free Report) is set to release its earnings data after the market closes on Tuesday, May 7th. Analysts expect Clover Health Investments to post earnings of ($0.07) per share for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its earnings results on Tuesday, March 12th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.06. Clover Health Investments had a negative return on equity of 62.58% and a negative net margin of 10.49%. The business had revenue of $510.25 million during the quarter, compared to analysts' expectations of $491.20 million. On average, analysts expect Clover Health Investments to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Clover Health Investments Price Performance

Shares of CLOV stock traded down $0.04 during mid-day trading on Tuesday, hitting $0.63. The stock had a trading volume of 4,035,843 shares, compared to its average volume of 8,585,857. Clover Health Investments has a 12-month low of $0.61 and a 12-month high of $1.63. The firm has a market capitalization of $312.03 million, a P/E ratio of -1.40 and a beta of 1.84. The firm's 50-day moving average is $0.77 and its two-hundred day moving average is $0.90.

Insiders Place Their Bets

In other news, Director Anna U. Loengard bought 137,000 shares of the stock in a transaction on Thursday, March 14th. The stock was acquired at an average cost of $0.73 per share, for a total transaction of $100,010.00. Following the acquisition, the director now owns 538,841 shares of the company's stock, valued at $393,353.93. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 21.82% of the company's stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.